These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 3118007

  • 1. Gold disposition in the rat: studies of its plasma half-life and its urinary, biliary and fecal elimination pathways.
    Massarella JW, Pearlman RS.
    J Pharmacol Exp Ther; 1987 Oct; 243(1):247-57. PubMed ID: 3118007
    [Abstract] [Full Text] [Related]

  • 2. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 3. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of gold sodium thiomalate.
    Waller ES, Massarella JW, Crout JE, Yakatan GJ.
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):33-47. PubMed ID: 6812186
    [Abstract] [Full Text] [Related]

  • 5. Distribution and disposition of trospectomycin sulfate in the in vivo rat, perfused rat liver, and cultured rat hepatocytes.
    Cox JW, Dring LG, Ginsberg LC, Larson PG, Constable DA, Ulrich RG.
    Drug Metab Dispos; 1990 Jul; 18(5):726-31. PubMed ID: 1981727
    [Abstract] [Full Text] [Related]

  • 6. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H, Matsunaga Y, Nambu K, Oh-e Y, Yoshida K, Hashimoto M.
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH, Cohn DA, Miller RR, Doss GA, Stearns RA, Simpson RE, Feeney WP, Chiu SH.
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [Abstract] [Full Text] [Related]

  • 8. Effect of repeated administration of chelating agents on distribution, excretion, and renal toxicity of gold sodium thiomalate in rats.
    Takahashi Y, Funakoshi T, Shimada H, Kiyozumi M, Kojima S.
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):253-6. PubMed ID: 1604050
    [Abstract] [Full Text] [Related]

  • 9. Altered hepatobiliary disposition of acetaminophen metabolites after phenobarbital pretreatment and renal ligation: evidence for impaired biliary excretion and a diffusional barrier.
    Brouwer KL, Jones JA.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):657-64. PubMed ID: 2313593
    [Abstract] [Full Text] [Related]

  • 10. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K, Okabe H, Sugeno K, Misaki A, Ito M, Kominami G, Esumi Y, Takaichi M, Harada T, Seki H, Inaba A.
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M, Monbaliu J, Meuldermans W, Hendriks R, Geerts R, Woestenborghs R, Heykants J.
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
    Jellum E, Munthe E, Guldal G, Aaseth J.
    Scand J Rheumatol Suppl; 1979 Jun; (28):28-36. PubMed ID: 109914
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs.
    Beconi MG, Reed JR, Teffera Y, Xia YQ, Kochansky CJ, Liu DQ, Xu S, Elmore CS, Ciccotto S, Hora DF, Stearns RA, Vincent SH.
    Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241
    [Abstract] [Full Text] [Related]

  • 16. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D, Siefert HM, Weber H, Rämsch K, Suwelack D.
    Arzneimittelforschung; 1985 Oct; 35(12):1781-6. PubMed ID: 4096729
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics, metabolism and disposition of salicylate in protein-deficient rats.
    Yue TL, Varma DR.
    Drug Metab Dispos; 1982 Oct; 10(2):147-52. PubMed ID: 6124400
    [Abstract] [Full Text] [Related]

  • 19. [Biliary, renal and fecal elimination and distribution of gold after a single oral administration of auranofin, quantified by the instrumental neutron activation analysis method].
    Benn HP, Schnier C, Bauer E, Seiler KU, Elhöft H, Löffler H.
    Z Rheumatol; 1991 Oct; 50(1):32-8. PubMed ID: 2058320
    [Abstract] [Full Text] [Related]

  • 20. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
    Meuldermans W, Hendrickx J, Lauwers W, Swysen E, Hurkmans R, Knaeps F, Woestenborghs R, Heykants J.
    Drug Metab Dispos; 1984 Oct; 12(6):772-81. PubMed ID: 6150829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.